ALL

News

EC approves blinatumomab for kids

The European Commission (EC) has expanded the approved indication for blinatumomab (Blincyto®), a bispecific, CD19-directed, CD3 T-cell engager...

News

Drug could be repurposed for T-ALL

Venetoclax might improve the treatment of certain patients with T-cell acute lymphoblastic leukemia (T-ALL), according to preclinical research...

News

Adult CCSs report financial hardships

Health-related financial hardship is common among adult survivors of childhood cancer, according to a study published in the Journal of the...

Pages